Skip to content

Evommune EVMN Materials and supplies

Materials and supplies at other companies

Norfolk Southern logo
Norfolk SouthernNSC
$312M+14.3%
Union Pacific logo
Union PacificUNP
$838M+12.2%
MGE Energy logo
MGE EnergyMGEE
$38.19M+4.4%
Portland General Electric logo
Portland General ElectricPOR
$99M+7.6%
OGS
ONE GASOGS
$92.99M+5.7%
Flowers Foods logo
Flowers FoodsFLO
$28.52M-11.0%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OtherInventorySupplies.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's materials and supplies.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's materials and supplies?
Evommune (EVMN) reported materials and supplies of $130.99K in Q1 2026.
What does materials and supplies mean?
Materials and supplies represent the inventory of essential items required for daily operations, maintenance, and facility upkeep. For a biotechnology company, this includes laboratory consumables, reagents, and other physical assets necessary to support research and development activities. Efficient management of these supplies is critical to maintaining uninterrupted clinical trial progress.